Ferumoxides
As of the edition of 20 October 2026, Ferumoxides is a drug: marketed, first approved in 1996 (US); no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1996
- Kind
- Unknown
- Brand name
- Feridex I.V.
- First approved
- 30 August 1996 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- AMAG Pharmaceuticals
- Registered trials
- 3, 0 stopped early
- Disease areas
- Bones, joints and muscles; Infections
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 2 | 2 | 0 | 0 |
| Phase 1 | 1 | 1 | 0 | 0 |
| All trials | 3 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| AMAG Pharmaceuticals | Acquired holder | 2008 to now |